Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Nov;55(3):e17–e23. doi: 10.1097/QAI.0b013e3181f275fd

Table 1.

Baseline characteristics of patients (n=1154) who enrolled in the ART programme between 2004 and 2009

Variable N (%) Median (IQR)

Gender Women 752 (65.2)
Men 402 (34.8)

Age (years) 31.9 (27.3; 37.5)

Residents in the study township Yes 1102 (95.5)
No 40 (3.5)
Unknown 12 (1.0)

Transferred in from another ART
service
No 1046 (90.6)
Yes 108 (9.4)

Year of initiating ART 2004 137 (11.9)
2005 242 (21.0)
2006 279 (24.2)
2007 153 (13.3)
2008 155 (13.4)
2009 188 (16.3)

WHO clinical stage1 1 106 (9.3)
2 166 (14.5)
3 585 (51.1)
4 287 (25.1)

Baseline CD4 (cell/μl)2 122 (54; 190)
1

10 missing values

2

114 missing values